US FDA Kills ISO Voluntary Audit Program As MDSAP Efforts Accelerate
This article was originally published in Clinica
Executive Summary
The US FDA has terminated its three-year-old ISO 13485 voluntary audit program, which gave medtech companies the chance for a one-year reprieve from an FDA inspection, to put all attention on the global Medical Device Single Audit Program.